-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats_CORE10A.pdf
January 01, 1999 - PROC W/O CC 30 0.00
294: DIABETES AGE >35 4004 0.56
295: DIABETES AGE 0-35 1651 0.23
296: NUTRITIONAL … 330 0.05
9: Sexually transmitted infections (not HIV or hepatitis) 80 0.01
10: Immunizations and screening … mellitus without complication 320 0.04
50: Diabetes mellitus with complications 8778 1.22
51: Other … 3038 0.42
75: Personal history of mental disorder, mental and behavioral problems, observation and
screening … admission 35 0.00
256: Medical examination/evaluation 419 0.06
257: Other aftercare 1081 0.15
258: Other screening
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats_CORE10B.PDF
January 01, 1998 - PROC W/O CC 30 0.00
294: DIABETES AGE >35 3829 0.56
295: DIABETES AGE 0-35 1448 0.21
296: NUTRITIONAL … 308 0.05
9: Sexually transmitted infections (not HIV or hepatitis) 99 0.01
10: Immunizations and screening … mellitus without complication 218 0.03
50: Diabetes mellitus with complications 8414 1.23
51: Other … 2813 0.41
75: Personal history of mental disorder, mental and behavioral problems, observation and
screening … admission 49 0.01
256: Medical examination/evaluation 278 0.04
257: Other aftercare 1316 0.19
258: Other screening
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats.PDF
January 01, 1998 - PROC W/O CC 257 0.00
294: DIABETES AGE >35 37543 0.55
295: DIABETES AGE 0-35 14847 0.22
296: NUTRITIONAL … 3084 0.05
9: Sexually transmitted infections (not HIV or hepatitis) 1050 0.02
10: Immunizations and screening … mellitus without complication 2173 0.03
50: Diabetes mellitus with complications 83770 1.23
51: Other … 27973 0.41
75: Personal history of mental disorder, mental and behavioral problems, observation and
screening … 450 0.01
256: Medical examination/evaluation 3000 0.04
257: Other aftercare 13177 0.19
258: Other screening
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2009_MaskedStats_Core_Weighted.PDF
January 01, 2009 - PROC W/O CC 135 0.00%
295: DIABETES AGE 0-35 48,074 0.65%
296: NUTRITIONAL & MISC METABOLIC DISORDERS … 2,617 0.04%
9: Sexually transmitted infections (not HIV or hepatitis) 843 0.01%
10: Immunizations and screening … mellitus without complication 9,102 0.12%
50: Diabetes mellitus with complications 40,176 0.55%
51 … 0.01%
256: Medical examination/evaluation 2,814 0.04%
257: Other aftercare 2,031 0.03%
258: Other screening … Substance-related disorders 16,327 0.22%
662: Suicide and intentional self-inflicted injury 387 0.01%
663: Screening
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
November 01, 2012 - outcomes (mortality, HRQoL [e.g., DLQI,
HAQ-DI, EQ-5D] and other patient-reported outcomes,
MACE, diabetes … There was
insufficient evidence to evaluate myocardial infarction and
diabetes mellitus, and no other
-
www.ahrq.gov/sites/default/files/2025-02/lofland-report.pdf
January 01, 2025 - Comorbid depression is associated with
increased health care use and expenditures in individuals with diabetes … Diabetes Care. 2002;25:464-70.
(43) Bond Trevor G, Fox Christine M.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alternative-payment-models-protocol.pdf
December 16, 2024 - will be excluded
• Outcomes
o Change/difference in patient health outcomes (e.g., hypertension, diabetes … emergency department and inpatient utilization [composite outcome], maternal morbidity,
hypertension and diabetes … patients with
serious mental illness, and patients with medical complexity or chronic diseases such as diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia_horizon-scan-high_impact-1306-revised.pdf
July 09, 2013 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures, treatments, screening … and nasal spray bottles.44,46,47 Various insulin products
already approved for use in patients with diabetes … They
thought that the drug’s well-known safety profile and long history of use (in diabetes) would
-
hcup-us.ahrq.gov/toolssoftware/ccs/AppendixASingleDX.txt
January 01, 2024 - 09955 09956 09959 0998 0999 79505 79515 79519 79675 79679
10 Immunizations and screening … 2441 2442 2443 2448 2449 2450 2451 2452 2453 2454 2458 2459 2460 2461 2462 2463 2468 2469 7945
49 Diabetes … 7895 78959
7904 7905 7948 V427
152 Pancreatic disorders (not diabetes … V5883 V5889 V589 V660 V665 V666 V667 V669 V670 V6700 V6701 V6709 V6751 V6759 V676 V679
258 Other screening … E9581 E9582 E9583
E9584 E9585 E9586 E9587 E9588 E9589 E959 V6284
663 Screening
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary52/vitamin-d-and-calcium-to-prevent-fractures-preventive-medication-2013
December 10, 2011 - (RCTs) of generally healthy adults (<20% of study participants had major chronic diseases, such as diabetes … Tufts Evidence-based Practice Center evidence report on vitamin D and calcium 5 , including abstract screening … Albanes D, Purdue MP, Abnet CC, Chatterjee N, et al; Prostate, Lung, Colorectal, and Ovarian Cancer Screening … vitamin D metabolites and breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Effectiveness
Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments, screening … Bethesda (MD): National
Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK), National
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-evidence-heart-disease.pdf
October 01, 2022 - well as full-text reports of titles and abstracts
deemed as potentially relevant after the abstract screening … All screening was done in DistillerSR and EndNote was used to
track citations. … Following screening, a clinical subject matter expert (SME), a physician specialist, received
the list … A
randomized trial of therapies for type 2
diabetes and coronary artery disease. N Engl
J Med. … the search for guidelines and systematic review
returned more than 16,000 potential citations for screening
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs024541-goss-final-report-2018.pdf
January 01, 2018 - "Medication/diabetes
medications/oral hypoglycemics/metformin".
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
September 01, 2014 - search identified 1,521 citations, of which 38 required full-text review after title and
abstract screening … anatomical causes such as strictures or
prolapsed organs, those with neurologic disorders such as diabetes … requiring an indwelling catheter or
clean intermittent catheterization for at least 1
month before screening … Classification: Efficacy
Study|Intervention Model: Crossover
Assignment|Masking: Open Label|Primary
Purpose: Screening … and
Symptoms of Overactive
Bladder (Urge,
Frequency)
Device: Interstim therapy
NCT01130415 Screening
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_executive.pdf
April 01, 2012 - development phase (Figure A) is a modified version of a
larger framework depicting the impact of both screening … Analytic framework for screening and treatment of open-angle glaucoma
KQ = Key Question; S = Key Questions … for the Comparative Effectiveness of Screening for Glaucoma; T = Key Questions for the Comparative … summarized in the AHRQ report titled Surgical Treatment
of Coexisting Cataract and Glaucoma.7
Article Screening … Two reviewers independently applied the
same inclusion criteria as used during abstract screening.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_disposition-comments.pdf
January 27, 2014 - The research gap portion is
much needed and you may
want to consider referencing
the 1999 American Diabetes … Consensus
Development Conference on
Diabetic Foot Wound Care 7-9
April 1999 Boston,
Massachusetts Diabetes … Margolis have been found useful for diabetes as well as
venous disease.
-
digital.ahrq.gov/sites/default/files/Quartz%20Assessment%20Report_Public%20Version_0.pdf
August 05, 2024 - regimens is an important reason for inadequate control of chronic
diseases such as heart failure, diabetes … What is the effect of mobile phone text message reminders
on medication adherence among adult type 2 diabetes … The Brief Medication Questionnaire: a tool for
screening patient adherence and barriers to adherence
-
cdsic.ahrq.gov/sites/default/files/2024-09/Quartz%20Assessment%20Report_Public%20Version_0.pdf
January 01, 2024 - regimens is an important reason for inadequate control of chronic
diseases such as heart failure, diabetes … What is the effect of mobile phone text message reminders
on medication adherence among adult type 2 diabetes … The Brief Medication Questionnaire: a tool for
screening patient adherence and barriers to adherence
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_research-protocol.pdf
November 30, 2014 - age, female sex, chronic diarrhea, nerve damage (such as from
injury, multiple sclerosis, or chronic diabetes … Citations determined
potentially eligible by either investigator will undergo full text screening. … Differences in screening decisions will be resolved by consultation between investigators and a
third
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
July 01, 2013 - headaches, and
irritability.4,22 Decongestants are used with caution, if
at all, in patients with diabetes … Overview
Of the 4,513 records identified through the literature
search, 4,458 were excluded during screening … Systematic Reviews and Meta-Analyses (PRISMA)53
diagram shown in Figure B depicts the flow of search
screening